Eating patterns before, during, and after obesity medication in adults with obesity

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows patients with obesity who are treated with obesity medications at St Vincent's University Hospital, Dublin, over an 18-month period. It aims to describe how hunger, fullness, thoughts about food, and meal size evolve as treatment begins, continues, and moves toward weight maintenance. The project emphasizes patients’ lived experiences of appetite and eating during real-world use of newer medications like GLP-1 receptor agonists. No experimental interventions are introduced beyond standard care, and data will be collected through patient experiences and related measures. The results may help clinicians understand how medication-related changes in eating behavior relate to weight outcomes over time.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Signed informed consent prior to any study-related procedure Age 16-80 years-old BMI range \> 27 kg/m2 Receiving obesity medication as part of usual care.

Exclusion Criteria:

* Substance abuse
* Pregnancy
* Regular use, for more than three times a week for the last 2 months and/or 7 days prior to inclusion, of medications which according to the principal investigator can interfere with the study.
* After being included in the study, starting any medication or treatment that could potentially influence the study participation and/or study analysis.
* Patients that have had bariatric surgery.

Where it's running

• St Vincent's University Hospital
  Dublin, Ireland Recruiting

Study contacts

• Study coordinator: Prof Carel W le Roux, MBChB, MSC, FRCP, FRCPath, PhD
• Email: Carel.leRoux@ucd.ie
• Phone: 353-1-4064781

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Real-Time Glucose Monitoring in Newly Diagnosed Type 2 Diabetes

  This study tests whether real-time glucose monitoring helps people with newly diagnosed type 2 diabetes manage glucose better than traditional finger-prick testing.

  Recruiting at 2 sites Bogomolets National Medical University · Kyiv and 2 other locations · NCT07690163

• Hydration Support to Help GLP-1 Therapy Side Effects

  This 17-week program tests whether boosting hydration in people starting GLP-1 receptor agonist therapy can lessen side effects and help people continue treatment.

  Recruiting State University of New York at Buffalo · Buffalo, New York · NCT07641361

• Explainable AI helps families manage obesity in kids and young adults with diabetes or asthma

  This study tests a family-centered digital program to help adolescents and young adults with overweight or obesity, including those with Type 1 diabetes or asthma, see if the program improves wellbeing and healthy habits over 3 months.

  Recruiting Adhera Health, Inc. · Seville · NCT07638345

• How incretin treatments affect muscle mass and function in people with overweight or obesity

  This study will see how drugs like semaglutide and tirzepatide influence fat-free mass, muscle strength, and physical function in adults with overweight or obesity.

  Recruiting Radboud University Medical Center · Amsterdam and 1 other locations · NCT07929831

• Dose find for remimazolam plus alfentanil for gastroscopy in obese adults

  This trial tests what dose of remimazolam besylate with alfentanil best sedates obese adults during gastroscopy.

  Recruiting Qianfoshan Hospital · Jinan, Shandong · NCT07925684

• Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults

  This study compares how much weight adults lose over two years when starting GLP-1 medicines versus adults who had sleeve gastrectomy at the same center.

  Recruiting Yuzuncu Yil University · Van · NCT07901777

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.